Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
FDA Draft Guidance on Multiregional Clinical Development Programs for Oncology
Blog Posts
WCG Clinical | Insights
Q&A: Framework for AI Adoption in Clinical Trials
Blog Posts
WCG Clinical | Insights
Navigating the Maze of Endpoint Adjudication Committees: Why Naming Conventions Matter for Your Clinical Trial
Blog Posts
WCG Clinical | Insights
The Contract Crisis: What WCG’s Latest Study Reveals About Clinical Research’s #1 Challenge
Blog Posts
WCG Clinical | Insights
Elevate Training to Overcome Site Burden and Reduce Protocol Deviations by 35-50%
Blog Posts
WCG Clinical | Insights
The FDA’s Updated IRB Bioresearch Monitoring (BIMO) Inspection Manual
Blog Posts
WCG Clinical | Insights
Protocol Deviations Explained: Understanding the FDA’s Draft Guidance
Blog Posts
WCG Clinical | Insights
Bulk Data Transfers: What Researchers Need to Know About Executive Order 14117 and 28 CFR Part 202
Blog Posts
WCG Clinical | Insights
Ensuring Representative US Enrollment in Oncology Clinical Trials: Navigating the Rising Tide of Regulatory Scrutiny
Blog Posts
WCG Clinical | Insights